1. Home
  2. WBX vs CRDL Comparison

WBX vs CRDL Comparison

Compare WBX & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$2.37

Market Cap

118.0M

ML Signal

HOLD

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$0.99

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
CRDL
Founded
2015
2017
Country
Spain
Canada
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
97.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WBX
CRDL
Price
$2.37
$0.99
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$9.00
$9.00
AVG Volume (30 Days)
33.3K
445.0K
Earning Date
02-26-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$174,593,453.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$37.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$0.77
52 Week High
$14.40
$1.59

Technical Indicators

Market Signals
Indicator
WBX
CRDL
Relative Strength Index (RSI) 25.90 46.12
Support Level $2.30 $0.94
Resistance Level $3.36 $1.03
Average True Range (ATR) 0.20 0.04
MACD -0.02 -0.00
Stochastic Oscillator 6.60 26.06

Price Performance

Historical Comparison
WBX
CRDL

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: